Real-time enrollment status for this refractory solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:47 AM UTC
| NCT Number | NCT06721689 |
| Recruiting Status | Recruiting |
| Condition | Refractory Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 59 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Theodore Laetsch |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 28, 2026: Clinical trial NCT06721689 is currently recruiting participants. This phase1 study for refractory solid tumors is actively seeking new participants at 7 locations across the United States. The study is sponsored by Theodore Laetsch. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06721689 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06721689 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.